GDF-15 in anticoagulated patients with AF has been found to be strongly associated with increased risk of major bleeding, independently of cardiovascular risk factors and other biomarkers, but only in these complex models, it was not associated with stroke/systemic embolism risk [8, 10–12]. This evidence concerns the gene GDF15 and atrial fibrillation.